Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-660-1 | CAS number: - Z-27
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 July to 17 August 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed to a guideline and used GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)
- EC Number:
- 421-660-1
- EC Name:
- Bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)
- Molecular formula:
- Hill formula: C50 H96 N2 O10 CAS formula: C42 H74 O8. 2(C4 H11 N O)
- IUPAC Name:
- bis((2-hydroxyethyl)dimethylazanium) (4E)-3-{[2-({3-carboxylato-3-[(2E)-hexadec-2-en-2-yl]propanoyl}oxy)ethoxy]carbonyl}-4-methyloctadec-4-enoate
- Reference substance name:
- BIS(DIMETHYL-(2-HYDROXYETHYL)AMMONIUM) 1,2-ETHANEDIYL-BIS (2-HEXADECENYLSUCCINATE)
- IUPAC Name:
- BIS(DIMETHYL-(2-HYDROXYETHYL)AMMONIUM) 1,2-ETHANEDIYL-BIS (2-HEXADECENYLSUCCINATE)
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Limited, Manston, Kent
- Age at study initiation: Approximately 5 to 7 weeks old
- Weight at study initiation: Males: 23-30 g; Females: 20 to 24 g
- Assigned to test groups randomly: Yes
- Fasting period before study: NDA
- Housing: The animals were housed in groups of up to 5 in solid floor polypropylene cages with woodflake bedding.
- Diet: Ad libitum - rat and mouse expanded diet
- Water: Ad libitum - mains drinking water
- Acclimation period: Minimum acclimisation period of 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25 °C
- Humidity (%): 50-65 %
- Air changes (per hr): 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours darkness
IN-LIFE DATES: NDA
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Arachis oil
- Justification for choice of solvent/vehicle: NDA
- Concentration of test material in vehicle: 0, 3.75, 7.5 and 15 mg test material per mL of vehicle
- Amount of vehicle (if gavage or dermal): N/A
- Type and concentration of dispersant aid: N/A
- Supplier's batch no.: 158
- Purity: NDA - Details on exposure:
- The test material was administered by intraperitoneal injection uisng a hypodermic needle attached to a graduated syringe.
- Duration of treatment / exposure:
- One group of mice from each dose group was killed 24 hours following treatment and a second at 48 hours.
- Frequency of treatment:
- Animals were dosed only once.
- Post exposure period:
- Either 24 or 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 37.5, 75 and 150 mg/kg
Basis:
nominal conc.
- No. of animals per sex per dose:
- Male: 37.5 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 75 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 150 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 37.5 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Male: 75 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Male: 150 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Female: 37.5 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 75 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 150 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 37.5 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
Female: 75 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
Female: 150 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 48 hours - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Positive control: Cyclophosphamide
- Justification for choice of positive control(s): It is known to produce micronuclei under the conditions of the test.
- Route of administration: Oral
- Doses / concentrations: Dose level: 50 mg/kg; Concentration: 5 mg/mL
Animals treated with the positive control were killed 24 hours after dosing.
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: With premature deaths at and above 300 mg/kg the maximum tolerated dose level selected for the main study was 150 mg/kg. These dose levels were selected with animal welfare issues in mind.
TREATMENT AND SAMPLING TIMES: All animals were observed for signs of overt toxicity and death one hour after dosing and then once daily as applicable. Animals were sacrificed either 24 or 48 hours after administration of the test material.
DETAILS OF SLIDE PREPARATION: Immediately following sacrifice, both femurs were dissected from each animal, asprated with foetal calf serum and bone marrow smears prepared following centrifugation and resuspension. The smears were dried, fixed in absolute methanol and stained in May-Grünwald/Giemsa, dried and coverslipped.
METHOD OF ANALYSIS: Stained bone marrow smears were examined 'blind' using light microscopy at x1000 magnification. The incidence of micronucleated cells per 1000 polychromatic erythrocytes (PCE-blue stained immature cells) per animal was scored. In addition, the number of normochromatic erythrocytes (NCE-pink stained mature cells) associated with 1000 polychromatic erythrocytes was counted; these cells were also scored for incidence of micronuclei.
The ratio of polychromatic to normochromatic erythrocytes was calculated together with appropriate group mean values for males and females separately and combined.
OTHER: NDA - Evaluation criteria:
- A positive mutagenic response is demonstrated when a statistically significant increase in the number of micronucleated polychromatic erythrocytes is observed for either the 24 or 48 hour kill times when compared to their corresponding control group.
If these criteria are not demonstrated, then the test material is considered to be non-genotoxic under the conditions of the test.
A positive response for bone marrow toxicity is demonstrated when the dose group mean polychromatic to normochromatic ratio is shown to be statistically significantly lower than the concurrent vehicle control group. - Statistics:
- The data were analysed using Student's t-test (two tailed).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- There was no statistically significant increase or change in the frequency of micronucleated PCEs or the PCE/NCE ratios in any of the test material dose groups when compared to their concurrent vehicle control groups.
- Toxicity:
- no effects
- Remarks:
- There were no premature deaths or clinical signs observed in any of the dose groups.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 75-2000 mg/kg
- Solubility: NDA
- Clinical signs of toxicity in test animals: Premature deaths were seen in animals dosed with the test material at and above 300 mg/kg. Clinical signs were observed above 100 mg/kg and included hunched posture, lethargy, pilo-erecion, ptosis, decreased respiratory rate, laboured respiration, ataxia, pallour of the extremities, distended abdomen, dehydration and tiptoe gait. The presence of clinical signs and premature deaths indicated that systemic absorption did occur.
- Evidence of cytotoxicity in tissue analyzed: N/A - no necropsies were performed
- Rationale for exposure: N/A
- Harvest times: N/A
- High dose with and without activation: N/A
- Other: NDA
RESULTS OF DEFINITIVE STUDY
- Types of structural aberrations for significant dose levels (for Cytogenetic or SCE assay): N/A
- Induction of micronuclei (for Micronucleus assay): There was no statistically significant increase in the frequency of micronucleated PCEs in any of the test material dose groups when compared to their concurrent vehicle control groups.
- Ratio of PCE/NCE (for Micronucleus assay): There was no statistically significant change in the PCE/NCE ratios in any of the test material dose groups when compared to their concurrent vehicle control groups.
- Appropriateness of dose levels and route: The steep toxicity curve seen in the range-finding study resulted in the selection of a maximum tolerated dose level that was expected to produce clinical signs in the main study. The absence of clinical signs in the main study was considered not to affect its integrity or validity.
- Statistical evaluation: See Table 1
Any other information on results incl. tables
Table 1 Summary of group mean data
Treatment group |
No. of PCE with micronuclei per 1000 PCE |
PCE/NCE ratio |
||
Group mean |
SD |
Group mean |
SD |
|
VEHICLE CONTROL 48 h sampling time |
0.5 |
0.7 |
0.95 |
0.27 |
VEHICLE CONTROL 24 h sampling time |
1.0 |
0.7 |
0.97 |
0.36 |
POSITIVE CONTROL 24 h sampling time |
28.0* |
7.8 |
0.77 |
0.15 |
150 mg/kg 48 h sampling time |
0.8 |
1.1 |
1.01 |
0.24 |
75 mg/kg 48 h sampling time |
0.7 |
0.9 |
0.99 |
0.47 |
37.5 mg/kg 48 h sampling time |
0.9 |
0.7 |
1.00 |
0.30 |
150 mg/kg 24 h sampling time |
1.4 |
1.2 |
1.08 |
0.47 |
75 mg/kg 24 h sampling time |
0.8 |
0.8 |
1.15 |
0.54 |
37.5 mg/kg 24 h sampling time |
1.4 |
1.5 |
1.11 |
0.29 |
SD = standard deviation
* = p less than 0.001
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
OS 114451A was considered to be non-genotoxic under the conditions of the test. - Executive summary:
In an albino CD-1 strain mouse bone marrow micronucleus assay, groups of 5 males and 5 females were treated via a single intraperitoneal dose with OS 114451A at doses of 0, 37.5, 75 and 100 mg/kg bw. Bone marrow cells were harvested at 24 and 48 hours post-treatment. The vehicle was arachis oil.
There were no signs of toxicity during the study. The positive control induced the appropriate response. There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.